USPTO serial 79324831
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
RICHARD E PARKE
RICHARD E PARKE WISSING MILLER LLP31 HUDSON YARDS 11TH FLOORINDUSTRIOUS AT HUDSON YARDSNEW YORK, NY 10001| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals, medical and veterinary preparations, for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical or veterinary use, food for babies; dietary supplements for human beings and animals; plasters for medical purposes, materials for dressings being medical dressings; medical plasters; material for stopping teeth, dental wax | ABANDONED | — |
| 010 | Surgical apparatus and instruments; Surgical apparatus and instruments for medical, dental or veterinary use | ABANDONED | — |
| 035 | Wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies | ABANDONED | — |
| 042 | Providing medical and scientific research information about the results of clinical trials for pharmaceutical products; research and development in the pharmaceutical and biotechnology fields; scientific research in the nature of conducting clinical trials for pharmaceutical products for others; development of pharmaceutical preparations and medicines; pharmaceutical products development; research on the subject of pharmaceuticals; laboratory research services relating to pharmaceuticals; pharmaceutical research services; medical research | ABANDONED | — |
| 044 | Medical consultations; medical counseling; medical information; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; nursing, medical; Pharmaceutical compounding services; provision of pharmaceutical medical information; Pharmaceutical advice | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 30, 2024 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 30, 2024 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 6, 2024 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Jun 6, 2024 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Jun 6, 2024 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jun 6, 2024 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Oct 21, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 24, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 5, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 5, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 21, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 22, 2023 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Feb 21, 2023 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Feb 21, 2023 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Feb 13, 2023 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Feb 13, 2023 | APET | ASSIGNED TO PETITION STAFF | — |
| Feb 1, 2023 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Dec 2, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 2, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 2, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 1, 2022 | WOAG | WITHDRAWAL OF ATTORNEY GRANTED | — |
| Dec 1, 2022 | WOAR | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | — |
| Nov 7, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Oct 25, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 25, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 5, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 19, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 8, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 8, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 23, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 23, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 31, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 30, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 4, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |